Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT07763028
PHASE1

Intrathecal Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells for Children With Cerebral Palsy

Sponsor: Gadjah Mada University

View on ClinicalTrials.gov

Summary

This is a single-center, open-label, single-arm Phase I pilot study designed to evaluate the feasibility and short-term safety of a single intrathecal administration of allogeneic umbilical cord tissue-derived mesenchymal stromal cells (UCT-MSCs) in children with cerebral palsy (CP).

Official title: Intrathecal Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells in Children With Cerebral Palsy: A Pilot Study of Feasibility, Short-Term Safety, and Exploratory Outcomes

Key Details

Gender

All

Age Range

2 Years - 5 Years

Study Type

INTERVENTIONAL

Enrollment

7

Start Date

2024-12-01

Completion Date

2026-09

Last Updated

2026-08-13

Healthy Volunteers

No

Interventions

BIOLOGICAL

allogeneic umbilical cord tissue-derived mesenchymal stromal cells (UCT-MSCs)

A single intrathecal dose of allogeneic umbilical cord tissue-derived mesenchymal stromal cells (UCT-MSCs) at 2 × 10⁶ viable cells/kg body weight

Locations (1)

Dr. Sardjito Hospital

Yogyakarta, D.I. Yogyakarta, Indonesia